Yinkang-009

N/A

Report date: 2025/03/20 09:21:14

Base Information

Drug NameYinkang-009
Drug Alias NameT cell immunoglobulin mucin-3 inhibitor (Yinkang Biopharma)
ClassificationBiologics
Mechanisms of ActionHepatitis A virus cellular receptor 2 inhibitors
TargetsHepatitis A virus cellular receptor 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYinkang Biopharma Inc.
China Registration ClassN/A

Develop Information

Active CompaniesYinkang Biopharma Inc.
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A